An Open Label, Single and Multiple Doses, Single-centre Study to Evaluate Pharmacokinetics, Safety and Tolerability of SNV004 in Chinese Healthy Subjects
Latest Information Update: 04 Aug 2020
At a glance
- Drugs Vibegron (Primary)
- Indications Overactive bladder; Pain
- Focus Pharmacokinetics
- 04 Aug 2020 New trial record